Inflammation  >>  MMI-0100  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MMI-0100 / Moerae Matrix, Teva
LPS, NCT02515396: Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide

Unknown status
1a
20
Europe
MMI-0100, Placebo
Moerae Matrix, Inc.
Acute Inflammatory Response to Non-antigenic Stimulus
03/16
06/17

Download Options